Cargando…

Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines

Detalles Bibliográficos
Autor principal: Maestroni, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481341/
https://www.ncbi.nlm.nih.gov/pubmed/32910359
http://dx.doi.org/10.1007/s11481-020-09956-1
_version_ 1783580580889231360
author Maestroni, Georges
author_facet Maestroni, Georges
author_sort Maestroni, Georges
collection PubMed
description
format Online
Article
Text
id pubmed-7481341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74813412020-09-10 Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines Maestroni, Georges J Neuroimmune Pharmacol Letter to the Editor Springer US 2020-09-10 2020 /pmc/articles/PMC7481341/ /pubmed/32910359 http://dx.doi.org/10.1007/s11481-020-09956-1 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Maestroni, Georges
Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title_full Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title_fullStr Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title_full_unstemmed Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title_short Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
title_sort exogenous melatonin as potential adjuvant in anti-sarscov2 vaccines
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481341/
https://www.ncbi.nlm.nih.gov/pubmed/32910359
http://dx.doi.org/10.1007/s11481-020-09956-1
work_keys_str_mv AT maestronigeorges exogenousmelatoninaspotentialadjuvantinantisarscov2vaccines